PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron.
Clin Transl Med
; 12(4): e806, 2022 04.
Article
in English
| MEDLINE | ID: covidwho-1777546
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Phosphoinositide-3 Kinase Inhibitors
/
SARS-CoV-2
/
COVID-19 Drug Treatment
Topics:
Variants
Limits:
Humans
Language:
English
Journal:
Clin Transl Med
Year:
2022
Document Type:
Article
Affiliation country:
Ctm2.806
Similar
MEDLINE
...
LILACS
LIS